Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01713972
Title Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Manisha Shah

Advanced Solid Tumor


Dabrafenib + Pazopanib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST